Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

NCT00179049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2008-12-15

No results posted yet for this study

Summary

The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease.

Conditions

  • Hematopoietic Stem Cell Transplantation
  • Graft vs Host Disease

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Adetola A Kassim, M.D. · Vanderbilt University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Completion
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00179049 on ClinicalTrials.gov